1. Home
  2. DFIN vs TRVI Comparison

DFIN vs TRVI Comparison

Compare DFIN & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donnelley Financial Solutions Inc.

DFIN

Donnelley Financial Solutions Inc.

HOLD

Current Price

$49.53

Market Cap

1.2B

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$11.01

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DFIN
TRVI
Founded
1983
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
DFIN
TRVI
Price
$49.53
$11.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$61.50
$20.38
AVG Volume (30 Days)
312.7K
1.1M
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.15
N/A
Revenue
$963,000,000.00
N/A
Revenue This Year
$4.98
N/A
Revenue Next Year
$3.87
N/A
P/E Ratio
$42.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.07
$4.85
52 Week High
$66.25
$14.39

Technical Indicators

Market Signals
Indicator
DFIN
TRVI
Relative Strength Index (RSI) 51.14 43.88
Support Level $44.35 $10.04
Resistance Level $55.58 $11.78
Average True Range (ATR) 2.08 0.73
MACD -0.03 -0.10
Stochastic Oscillator 40.74 8.00

Price Performance

Historical Comparison
DFIN
TRVI

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: